Edwards Lifesciences (EW) Other Non-Current Assets (2009 - 2026)

Edwards Lifesciences has reported Other Non-Current Assets for 18 years, with the latest figure at $616.4 million in Q2 2026.

• On a quarterly basis, Other Non-Current Assets fell 17.04% year-over-year to $616.4 million in Q2 2026; TTM through Jun 2026 was $616.4 million, a 17.04% decrease from a year earlier, with the FY2025 full-year figure at $730.2 million, up 1.19% from the prior year.
• Other Non-Current Assets was $616.4 million for Q2 2026 at Edwards Lifesciences, down from $738.9 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $789.8 million in Q2 2024, with the low at $129.4 million in Q1 2022.
• Average Other Non-Current Assets over 5 years is $550.8 million, with a median of $649.9 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Other Non-Current Assets jumped 169.95% in 2022, then retreated 17.04% in 2026.
• Over 5 years, Other Non-Current Assets stood at $299.1 million in 2022, then jumped by 54.86% to $463.2 million in 2023, then surged by 55.79% to $721.6 million in 2024, then advanced by 1.19% to $730.2 million in 2025, then dropped by 15.58% to $616.4 million in 2026.
• The last three Other Non-Current Assets figures came in at $616.4 million (Q2 2026), $738.9 million (Q1 2026), and $730.2 million (Q4 2025), per Business Quant data.